243 related articles for article (PubMed ID: 27852123)
1. Acanthopanax senticosus: Photochemistry and Anticancer Potential.
Li T; Ferns K; Yan ZQ; Yin SY; Kou JJ; Li D; Zeng Z; Yin L; Wang X; Bao HX; Zhou YJ; Li QH; Zhao ZY; Liu H; Liu SL
Am J Chin Med; 2016; 44(8):1543-1558. PubMed ID: 27852123
[TBL] [Abstract][Full Text] [Related]
2. Acanthopanax senticosus: review of botany, chemistry and pharmacology.
Huang L; Zhao H; Huang B; Zheng C; Peng W; Qin L
Pharmazie; 2011 Feb; 66(2):83-97. PubMed ID: 21434569
[TBL] [Abstract][Full Text] [Related]
3. Constituents and pharmacological effects of Eucommia and Siberian ginseng.
Deyama T; Nishibe S; Nakazawa Y
Acta Pharmacol Sin; 2001 Dec; 22(12):1057-70. PubMed ID: 11749801
[TBL] [Abstract][Full Text] [Related]
4. A comparative study on root and bark extracts of Eleutherococcus senticosus and their effects on human macrophages.
Jin L; Schmiech M; El Gaafary M; Zhang X; Syrovets T; Simmet T
Phytomedicine; 2020 Mar; 68():153181. PubMed ID: 32065954
[TBL] [Abstract][Full Text] [Related]
5. Proliferative and Inhibitory Activity of Siberian ginseng (Eleutherococcus senticosus) Extract on Cancer Cell Lines; A-549, XWLC-05, HCT-116, CNE and Beas-2b.
Cichello SA; Yao Q; Dowell A; Leury B; He XQ
Asian Pac J Cancer Prev; 2015; 16(11):4781-6. PubMed ID: 26107240
[TBL] [Abstract][Full Text] [Related]
6. Enrichment and purification of syringin, eleutheroside E and isofraxidin from Acanthopanax senticosus by macroporous resin.
Yang F; Yang L; Wang W; Liu Y; Zhao C; Zu Y
Int J Mol Sci; 2012; 13(7):8970-8986. PubMed ID: 22942746
[TBL] [Abstract][Full Text] [Related]
7. A review of Acanthopanax senticosus (Rupr and Maxim.) harms: From ethnopharmacological use to modern application.
Jia A; Zhang Y; Gao H; Zhang Z; Zhang Y; Wang Z; Zhang J; Deng B; Qiu Z; Fu C
J Ethnopharmacol; 2021 Mar; 268():113586. PubMed ID: 33212178
[TBL] [Abstract][Full Text] [Related]
8. Bioactivity-guided fractionation for anti-fatigue property of Acanthopanax senticosus.
Huang LZ; Huang BK; Ye Q; Qin LP
J Ethnopharmacol; 2011 Jan; 133(1):213-9. PubMed ID: 20920564
[TBL] [Abstract][Full Text] [Related]
9. Active components from Siberian ginseng (Eleutherococcus senticosus) for protection of amyloid β(25-35)-induced neuritic atrophy in cultured rat cortical neurons.
Bai Y; Tohda C; Zhu S; Hattori M; Komatsu K
J Nat Med; 2011 Jul; 65(3-4):417-23. PubMed ID: 21301979
[TBL] [Abstract][Full Text] [Related]
10. Authentication of the traditional medicinal plant Eleutherococcus senticosus by DNA and chemical analyses.
Maruyama T; Kamakura H; Miyai M; Komatsu K; Kawasaki T; Fujita M; Shimada H; Yamamoto Y; Shibata T; Goda Y
Planta Med; 2008 Jun; 74(7):787-9. PubMed ID: 18500683
[TBL] [Abstract][Full Text] [Related]
11. High-throughput ultra high performance liquid chromatography combined with mass spectrometry approach for the rapid analysis and characterization of multiple constituents of the fruit of Acanthopanax senticosus (Rupr. et Maxim.) Harms.
Han Y; Zhang A; Sun H; Zhang Y; Meng X; Yan G; Liu L; Wang X
J Sep Sci; 2017 May; 40(10):2178-2187. PubMed ID: 28371133
[TBL] [Abstract][Full Text] [Related]
12. Diacylglycerol acyltransferase 1 (DGAT1) inhibition by furofuran lignans from stems of Acanthopanax senticosus.
Li BB; Li JL; Li N; Qi SZ; Lee HS; Zhang L; Xing SS; Tuo ZD; Cui L
Arch Pharm Res; 2017 Nov; 40(11):1271-1277. PubMed ID: 27704334
[TBL] [Abstract][Full Text] [Related]
13. A new lignan glycoside from Eleutherococcus senticosus.
Li XC; Barnes DL; Khan IA
Planta Med; 2001 Nov; 67(8):776-8. PubMed ID: 11731930
[TBL] [Abstract][Full Text] [Related]
14. Isofraxidin, a coumarin component from Acanthopanax senticosus, inhibits matrix metalloproteinase-7 expression and cell invasion of human hepatoma cells.
Yamazaki T; Tokiwa T
Biol Pharm Bull; 2010; 33(10):1716-22. PubMed ID: 20930381
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection or neurotoxicity? new insights into the effects of Acanthopanax senticosus harms on nervous system through cerebral metabolomics analysis.
Zhang SN; Li XZ; wang Y; zhang N; Yang ZM; Liu SM; Lu F
J Ethnopharmacol; 2014 Oct; 156():290-300. PubMed ID: 25223591
[TBL] [Abstract][Full Text] [Related]
16. A new 3,4-seco-lupane-type triterpenoid from the pulp of Acanthopanax senticosus (Rupr. et Maxim) Harms.
Yan ZW; Liu JP; Lu D; Groundwater P; He CY; Li PY
Nat Prod Res; 2010 Oct; 24(16):1523-7. PubMed ID: 20835953
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the multiple components of Acanthopanax Senticosus stem by ultra high performance liquid chromatography with quadrupole time-of-flight tandem mass spectrometry.
Sun H; Liu J; Zhang A; Zhang Y; Meng X; Han Y; Zhang Y; Wang X
J Sep Sci; 2016 Feb; 39(3):496-502. PubMed ID: 26632031
[TBL] [Abstract][Full Text] [Related]
18. Increase of beta-endorphin secretion by syringin, an active principle of Eleutherococcus senticosus, to produce antihyperglycemic action in type 1-like diabetic rats.
Niu HS; Hsu FL; Liu IM; Cheng JT
Horm Metab Res; 2007 Dec; 39(12):894-8. PubMed ID: 18075969
[TBL] [Abstract][Full Text] [Related]
19. Anti-oxidant activities of Acanthopanax senticosus stems and their lignan components.
Lee S; Son D; Ryu J; Lee YS; Jung SH; Kang J; Lee SY; Kim HS; Shin KH
Arch Pharm Res; 2004 Jan; 27(1):106-10. PubMed ID: 14969348
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemic effect of syringin from Eleutherococcus senticosus in streptozotocin-induced diabetic rats.
Niu HS; Liu IM; Cheng JT; Lin CL; Hsu FL
Planta Med; 2008 Feb; 74(2):109-13. PubMed ID: 18203055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
